{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:56:13Z","timestamp":1788954973236,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T00:00:00Z","timestamp":1387324800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00296-013-2921-y","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T08:22:47Z","timestamp":1387268567000},"page":"393-399","source":"Crossref","is-referenced-by-count":23,"title":["Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases"],"prefix":"10.1007","volume":"34","author":[{"given":"Lech","family":"Chrostek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Cylwik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Gindzienska-Sieskiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Gruszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Szmitkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislaw","family":"Sierakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,18]]},"reference":[{"key":"2921_CR1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10719-006-7922-6","volume":"23","author":"SK Raghav","year":"2006","unstructured":"Raghav SK, Gupta B, Agrawal C, Saroha A, Das RH, Chaturvedi VP, Das HR (2006) Altered expression and glycosylation of plasma proteins in rheumatoid arthritis. Glycoconj J 23:167\u2013173","journal-title":"Glycoconj J"},{"key":"2921_CR2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0925-4439(99)00057-5","volume":"1455","author":"JS Axford","year":"1999","unstructured":"Axford JS (1999) Glycosylation and rheumatic disease. Biochim Biophys Acta 1455:219\u2013229","journal-title":"Biochim Biophys Acta"},{"key":"2921_CR3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","volume":"313","author":"Y Kaneko","year":"2006","unstructured":"Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313:670\u2013673","journal-title":"Science"},{"key":"2921_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","volume":"320","author":"RM Anthony","year":"2008","unstructured":"Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV (2008) Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320:373\u2013376. doi: 10.1126\/science.1154315","journal-title":"Science"},{"key":"2921_CR5","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.molimm.2006.09.005","volume":"44","author":"BJ Scallon","year":"2007","unstructured":"Scallon BJ, Tam SH, McCarthy SG, Cai AN, Raju TS (2007) Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 44:1524\u20131534","journal-title":"Mol Immunol"},{"key":"2921_CR6","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1073\/pnas.0702936104","volume":"104","author":"F Nimmerjahn","year":"2007","unstructured":"Nimmerjahn F, Anthony RM, Ravetch JV (2007) Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci USA 104:8433\u20138437","journal-title":"Proc Natl Acad Sci USA"},{"key":"2921_CR7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10719-007-9049-9","volume":"24","author":"M Przybysz","year":"2007","unstructured":"Przybysz M, Maszczak D, Borysewicz K, Szechinski J, Katnik-Prastowska I (2007) Relative sialylation and fucosylation of synovial and plasma fibronectins in relation to the progression and activity of rheumatoid arthritis. Glycoconj J 24:543\u2013550","journal-title":"Glycoconj J"},{"key":"2921_CR8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00302152","volume":"12","author":"RA Feelders","year":"1992","unstructured":"Feelders RA, Vreugdenhil G, de Jong G, Swaak AJG, van Eijk HG (1992) Transferrin microheterogeneity in rheumatoid arthritis. Rheumatol Int 12:195\u2013199","journal-title":"Rheumatol Int"},{"key":"2921_CR9","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.jchromb.2011.04.024","volume":"879","author":"A Saroha","year":"2011","unstructured":"Saroha A, Biswas S, Chatterjee BP, Das HR (2011) Altered glycosylation and expression of plasma alpha-1-acid glycoprotein and haptoglobin in rheumatoid arthritis. J Chromatogr B Analyt Technol Biomed Life Sci 879:1839\u20131843. doi: 10.1016\/j.jchromb.2011.04.024","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2921_CR10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2478\/v10039-010-0006-7","volume":"55","author":"B Cylwik","year":"2010","unstructured":"Cylwik B, Chrostek L, Gindzienska-Sieskiewicz E, Sierakowski S, Szmitkowski M (2010) Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis. Adv Med Sci 55:80\u201385. doi: 10.2478\/v10039-010-0006-7","journal-title":"Adv Med Sci"},{"key":"2921_CR11","first-page":"410","volume":"44","author":"R Paul","year":"1989","unstructured":"Paul R, Rotzsch W (1989) The diagnostic significance of mucoproteins, sialic acid and cortisol in assessing the activity of rheumatic diseases. Z Gesamte Inn Med 44:410\u2013413","journal-title":"Z Gesamte Inn Med"},{"key":"2921_CR12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1620\/tjem.213.241","volume":"213","author":"AA Alturfan","year":"2007","unstructured":"Alturfan AA, Uslu EU, Alturfan EE, Hatemi G, Fresko I, Kokoglu E (2007) Increased serum sialic acid levels in primary osteoarthritis and inactive rheumatoid arthritis. Tohoku J Exp Med 213:241\u2013248","journal-title":"Tohoku J Exp Med"},{"key":"2921_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/bj1590457","volume":"159","author":"L Skoza","year":"1976","unstructured":"Skoza L, Mohos S (1976) Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assays in analytical De-O-acetylation. Biochem J 159:457\u2013462","journal-title":"Biochem J"},{"key":"2921_CR14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1155\/2008\/493289","volume":"25","author":"O Gornik","year":"2008","unstructured":"Gornik O, Lauc G (2008) Glycosylation of serum proteins in inflammatory diseases. Dis Markers 25:267\u2013278","journal-title":"Dis Markers"},{"key":"2921_CR15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10719-006-5409-0","volume":"23","author":"M Pasek","year":"2006","unstructured":"Pasek M, Duk M, Podbielska M, Sokolik R, Szechinski J, Lisowska E, Krotkiewski H (2006) Galactosylation of IgG from rheumatoid arthritis (RA) patients: changes during therapy. Glycoconj J 23:463\u2013471","journal-title":"Glycoconj J"},{"key":"2921_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0009-9120(99)00060-0","volume":"32","author":"I Gornik","year":"1999","unstructured":"Gornik I, Maravic G, Dumic J, Flogel M, Lauc G (1999) Fucosylation of IgG heavy chains is increased in rheumatoid arthritis. Clin Biochem 32:605\u2013608","journal-title":"Clin Biochem"},{"key":"2921_CR17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/oxfordjournals.jbchem.a022794","volume":"128","author":"A Matsumoto","year":"2000","unstructured":"Matsumoto A, Shikata K, Takeuchi F, Kojima N, Mizuochi T (2000) Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation. J Biochem 128:621\u2013628","journal-title":"J Biochem"},{"key":"2921_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00286135","volume":"2","author":"CP Maury","year":"1982","unstructured":"Maury CP, Helve T, Sj\u00f6blom C (1982) Serum beta 2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus. Rheumatol Int 2:145\u2013149","journal-title":"Rheumatol Int"},{"key":"2921_CR19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7888\/juoeh.7.401","volume":"7","author":"T Ota","year":"1985","unstructured":"Ota T, Uemura A, Eto S, Suzuki H (1985) Clinical significance of serum sialic acid in rheumatoid arthritis and systemic lupus erythematosus. J Uoeh 7:401\u2013407","journal-title":"J Uoeh"},{"key":"2921_CR20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448\u2013454","journal-title":"N Engl J Med"},{"key":"2921_CR21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12026-013-8384-0","volume":"561","author":"W Ansar","year":"2013","unstructured":"Ansar W, Ghosh S (2013) C-reactive protein and the biology of disease. Immunol Res 561:131\u2013142. doi: 10.1007\/s12026-013-8384-0","journal-title":"Immunol Res"},{"key":"2921_CR22","first-page":"456","volume":"35","author":"I Silva","year":"2010","unstructured":"Silva I, Mateus M, Branco JC (2010) Assessment of erythrocyte sedimentation rate (ESR) and C- reactive protein (CRP) on rheumatoid arthritis activity prediction. Acta Rheumatol Port 35:456\u2013462","journal-title":"Acta Rheumatol Port"},{"key":"2921_CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0307-742X(21)00201-0","volume":"8","author":"MB Pepys","year":"1982","unstructured":"Pepys MB, Lanham JG, De Beer FC (1982) C-reactive protein in SLE. Clin Rheum Dis 8:91\u2013103","journal-title":"Clin Rheum Dis"},{"key":"2921_CR24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1365-2249.1998.00655.x","volume":"113","author":"SA Bell","year":"1998","unstructured":"Bell SA, Faust H, Schmid A, Meurer M (1998) Autoantibodies to C-reactive protein and other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol 113:327\u2013332","journal-title":"Clin Exp Immunol"},{"key":"2921_CR25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2004.08.018","volume":"178","author":"A Kovacs","year":"2005","unstructured":"Kovacs A, Green F, Hansson LO, Lundman P, Samnegard A, Boquist S, Ericsson CG, Watkins H, Hamsten A, Tornvall P (2005) A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 178:193\u2013198","journal-title":"Atherosclerosis"},{"key":"2921_CR26","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/acr.21716","volume":"64","author":"C Muangchan","year":"2012","unstructured":"Muangchan C, Harding S, Khimdas S, Bonner A, The Canadian Scleroderma Research Group, Baron M, Pope J (2012) Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian scleroderma research group. Arthritis Care Res 64:1405\u20131414. doi: 10.1002\/acr.21716","journal-title":"Arthritis Care Res"},{"key":"2921_CR27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138920307779941497","volume":"8","author":"F Ceciliani","year":"2007","unstructured":"Ceciliani F, Pocacqua V (2007) The acute phase protein \u03b11-acid glycoprotein: a model for altered glycosylation during diseases. Curr Protein Peptide Sci 8:91\u2013108","journal-title":"Curr Protein Peptide Sci"},{"key":"2921_CR28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0009-8981(92)90211-8","volume":"210","author":"MJ Treuheit","year":"1992","unstructured":"Treuheit MJ, Halsall HB (1992) Disease-coupled specificity in the glycan structures of orosomucoid. Clin Chim Acta 210:237\u2013239","journal-title":"Clin Chim Acta"},{"key":"2921_CR29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.177.3.657","volume":"177","author":"TW Graaf De","year":"1993","unstructured":"De Graaf TW, Van der Stelt ME, Anbergen MG, van Dijk W (1993) Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 177:657\u2013666","journal-title":"J Exp Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2921-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2921-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2921-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T22:38:26Z","timestamp":1647729506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2921-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,18]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["2921"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2921-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,18]]}}}